Integrated needle-free injection and sensing using opto-microfluidics
iSENS is developing BoldJet, a portable needle-free injector using thermocavitation microjets for precise, safe, and environmentally friendly medication delivery, enhancing patient compliance and healthcare outcomes.
Projectdetails
Introduction
Needle-based injections have revolutionised healthcare by providing an efficient delivery method for medications, such as vaccines. However, there are significant drawbacks associated with using needles on a societal, environmental, and technological level.
Challenges of Needle Use
Needle phobia and infection risks can significantly impact patient compliance and safety with medical treatments. Additionally, millions of used needles contaminate the environment every day. Lastly, the effectiveness of certain drugs increases when injected intradermally, but targeting the dermis is challenging.
Project Overview
With iSENS, we want to revolutionise the experience of people who receive and perform frequent injections. To this end, we are developing and commercialising a portable and needle-free injector called BoldJet. Our technological breakthrough is threefold:
-
Needle-Free Injection Breakthrough: We introduce an innovative needle-free injection technology, globally pioneering the use of thermocavitation microjets. Our system excels in the precise and consistent delivery of liquids into the skin's superficial layers, surpassing current state-of-the-art methods.
-
Smart Sensing Capability: The BoldJet device will incorporate cutting-edge sensing technology, enabling it to assess the unique properties of the patient's skin before each injection. This breakthrough allows for semi-automatic calibration, tailoring the injection parameters to the specific skin type and treatment area.
-
Real-Time Monitoring and Precision: BoldJet goes beyond conventional methods by offering real-time monitoring of injection depth and volume. This feature guarantees that each dose is administered accurately and consistently.
Conclusion
With our triple technology platform, we will offer safer, more effective, and minimally invasive injections that do not contaminate our environment. This patient-friendly technology will result in a positive effect on society, allowing millions of people to receive better and more personalised healthcare.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.999 |
Totale projectbegroting | € 2.512.500 |
Tijdlijn
Startdatum | 1-7-2024 |
Einddatum | 30-6-2027 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- FLOWBEAMS BVpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to LabBiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening. | EIC Transition | € 2.500.000 | 2022 | Details |
MICRO-MECHANICAL PUMP FOR NEXT GENERATION INSULIN DELIVERY SYSTEMSPRISMA aims to validate a novel, ultra-compact micropump for wearable insulin delivery, enhancing accuracy and efficiency to revolutionize diabetes treatment and enable multi-drug systems. | EIC Transition | € 2.499.838 | 2022 | Details |
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to Lab
BiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening.
MICRO-MECHANICAL PUMP FOR NEXT GENERATION INSULIN DELIVERY SYSTEMS
PRISMA aims to validate a novel, ultra-compact micropump for wearable insulin delivery, enhancing accuracy and efficiency to revolutionize diabetes treatment and enable multi-drug systems.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Skin micro-injectorBold-Jet aims to revolutionize needle-free injections with a microjet device that enhances safety, minimizes invasiveness, and improves patient adherence to treatments. | ERC Proof of... | € 150.000 | 2022 | Details |
Overcoming limits for pre-clinical small volume liquid delivery into skin and inflammation quantificationThis project aims to validate the BuBble Gun injection method using Skin-On-Chip technology for localized drug testing in chronic skin diseases, paving the way for innovative treatment delivery. | ERC Proof of... | € 150.000 | 2025 | Details |
Dermaal microinjectie systeem met holle micronaalden voor oa vaccinatiesDit project onderzoekt de haalbaarheid van een pijnloos micro-injectiesysteem voor nauwkeurige medicatietoediening, met potentieel voor kankervaccinaties en verbeterde vaccinatiecapaciteit. | Mkb-innovati... | € 20.000 | 2021 | Details |
Epinefrine Auto Injector innovationDit project onderzoekt een innovatieve, patiënt-specifieke Epinefrine Auto-Injector pen om de effectiviteit en toegankelijkheid van anafylaxiebehandeling te verbeteren. | Mkb-innovati... | € 20.000 | 2020 | Details |
NEW PRODUCTION METHOD OF INJECTABLE MICROCAPSULES FOR PULSATILE VACCINE DELIVERYIamFluidics onderzoekt de haalbaarheid van 'in-air microfluidics' voor het produceren van polylactic acid microcapsules voor gecontroleerde vaccinafgifte, met als doel een kosteneffectieve, pulsatile injectieoplossing. | Mkb-innovati... | € 20.000 | 2022 | Details |
Skin micro-injector
Bold-Jet aims to revolutionize needle-free injections with a microjet device that enhances safety, minimizes invasiveness, and improves patient adherence to treatments.
Overcoming limits for pre-clinical small volume liquid delivery into skin and inflammation quantification
This project aims to validate the BuBble Gun injection method using Skin-On-Chip technology for localized drug testing in chronic skin diseases, paving the way for innovative treatment delivery.
Dermaal microinjectie systeem met holle micronaalden voor oa vaccinaties
Dit project onderzoekt de haalbaarheid van een pijnloos micro-injectiesysteem voor nauwkeurige medicatietoediening, met potentieel voor kankervaccinaties en verbeterde vaccinatiecapaciteit.
Epinefrine Auto Injector innovation
Dit project onderzoekt een innovatieve, patiënt-specifieke Epinefrine Auto-Injector pen om de effectiviteit en toegankelijkheid van anafylaxiebehandeling te verbeteren.
NEW PRODUCTION METHOD OF INJECTABLE MICROCAPSULES FOR PULSATILE VACCINE DELIVERY
IamFluidics onderzoekt de haalbaarheid van 'in-air microfluidics' voor het produceren van polylactic acid microcapsules voor gecontroleerde vaccinafgifte, met als doel een kosteneffectieve, pulsatile injectieoplossing.